Biceltis 440mg Injection is a biologic therapy designed for the treatment of moderate to severe inflammatory conditions, including rheumatoid arthritis, Crohn's disease, and ulcerative colitis. The active ingredient, Infliximab, is a monoclonal antibody that specifically targets and inhibits tumor necrosis factor-alpha (TNF-alpha), a protein responsible for driving inflammation in the body. By blocking this protein, Biceltis helps reduce the symptoms of inflammation, decrease disease activity, and prevent further damage to joints and tissues.

Key Features:

• Active Ingredient: Infliximab, a TNF-alpha inhibitor.
• Indications: Used for rheumatoid arthritis, Crohn's disease, and ulcerative colitis.
• Effectiveness: Helps reduce inflammation, prevent joint damage, and alleviate symptoms.
• Convenient Administration: Administered via IV infusion under medical supervision.

Benefits:

• Reduces inflammation and disease activity.
• Helps prevent damage to joints and tissues.

Administration: Biceltis 440mg Injection is administered intravenously by a healthcare professional. The dosage and frequency of administration depend on the specific condition being treated and the patient's response.

Precautions:

• Ensure the patient is not allergic to Infliximab or other components.
• Patients should be monitored for potential side effects such as infections or infusion-related reactions.
• Regular follow-ups and testing are necessary to track treatment progress.

FAQs:

1.What is Biceltis 440mg Injection used for?

Biceltis 440mg Injection is used to treat moderate to severe inflammatory conditions, such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis. It helps reduce inflammation and prevents further damage to tissues and joints by inhibiting tumor necrosis factor-alpha (TNF-alpha).

2.How does Biceltis 440mg Injection work?

The active ingredient, Infliximab, is a monoclonal antibody that targets and inhibits TNF-alpha, a protein responsible for triggering inflammation in the body. By blocking TNF-alpha, Biceltis helps decrease inflammation, reduce disease activity, and prevent tissue damage.

3.How is Biceltis 440mg Injection administered? Biceltis 440mg Injection is administered intravenously (IV) by a healthcare professional. The dosage and frequency of the infusions will depend on the condition being treated and the patient's response to therapy.

4.What are the common side effects of Biceltis 440mg Injection?

Common side effects include:

• Infusion-related reactions (e.g., fever, chills, headaches, dizziness)
• Respiratory infections
• Nausea
• Fatigue

5.Are there any serious side effects of Biceltis 440mg Injection?

Although rare, serious side effects can include severe allergic reactions, infections (e.g., tuberculosis, fungal infections), and liver problems. If you experience symptoms such as fever, persistent cough, yellowing of the skin or eyes, or severe abdominal pain, seek medical attention immediately.

6.How often do I need to receive Biceltis 440mg Injection?

The frequency of Biceltis injections depends on the condition being treated. Initially, infusions are given at regular intervals (e.g., at weeks 0, 2, and 6), followed by maintenance doses every 8 weeks or as prescribed by your healthcare provider.

7.Can I take Biceltis 440mg Injection while pregnant or breastfeeding.

The safety of Biceltis during pregnancy or breastfeeding has not been fully established. Consult your doctor before using Biceltis if you are pregnant, planning to conceive, or breastfeeding.

8.Can I drink alcohol while receiving Biceltis 440mg Injection?

It is advisable to avoid excessive alcohol consumption while undergoing treatment with Biceltis, as it may increase the risk of liver damage or interact with other medications.